Haemonetics 2nd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website
Haemonetics (NYSE: HAE) announced the availability of its second quarter fiscal year 2025 financial results, ended September 28, 2024, on its Investor Relations website. The company will host a conference call and webcast with investors and analysts on November 7, 2024, at 8:00 a.m. ET to discuss the results. Participants are recommended to join 10 minutes before the event starts. A replay of the conference call and webcast will be available for one year starting November 7, 2024, at 11:00 a.m. ET.
Haemonetics (NYSE: HAE) ha annunciato la disponibilit脿 dei risultati finanziari del secondo trimestre dell'anno fiscale 2025, conclusosi il 28 settembre 2024, sul suo sito web per le relazioni con gli investitori. L'azienda ospiter脿 una call e webcast con investitori e analisti il 7 novembre 2024, alle 8:00 ET per discutere i risultati. Si consiglia ai partecipanti di unirsi 10 minuti prima dell'inizio dell'evento. La registrazione della call e del webcast sar脿 disponibile per un anno a partire dal 7 novembre 2024, alle 11:00 ET.
Haemonetics (NYSE: HAE) anunci贸 la disponibilidad de los resultados financieros del segundo trimestre del a帽o fiscal 2025, que finaliz贸 el 28 de septiembre de 2024, en su sitio web de relaciones con los inversores. La compa帽铆a llevar谩 a cabo una conferencia telef贸nica y webcast con inversores y analistas el 7 de noviembre de 2024, a las 8:00 a.m. ET para discutir los resultados. Se recomienda a los participantes unirse 10 minutos antes de que comience el evento. Una reproducci贸n de la conferencia telef贸nica y el webcast estar谩 disponible durante un a帽o a partir del 7 de noviembre de 2024, a las 11:00 a.m. ET.
Haemonetics (NYSE: HAE)電� 2024雲� 9鞗� 28鞚� 膦呺霅� 2025 須岅硠鞐半弰 2攵勱赴 鞛 瓴瓣臣鞚� 臧�鞖╈劚鞚� 韴瀽鞛� 甏�瓿� 鞗轨偓鞚错姼鞐� 氚滍憸頄堨姷雼堧嫟. 須岇偓電� 2024雲� 11鞗� 7鞚� 鞓れ爠 8鞁�(ET)鞐� 韴瀽鞛� 氚� 攵勳劃臧�鞕� 頃粯 瓴瓣臣毳� 雲检潣頃橁赴 鞙勴暣 鞝勴檾 須岇潣 氚� 鞗轨簮鞀ろ姼毳� 臧滌禍頃� 鞓堨爼鞛呺媹雼�. 彀戈皜鞛愲姅 鞚措菠韸� 鞁滌瀾 10攵� 鞝勳棎 彀胳棳頃橂姅 瓴冹澊 甓岇灔霅╇媹雼�. 鞝勴檾 須岇潣 氚� 鞗轨簮鞀ろ姼鞚� 鞛儩鞚� 2024雲� 11鞗� 7鞚� 鞓れ爠 11鞁�(ET)攵�韯� 1雲� 霃欖晥 靷毄頃� 靾� 鞛堨姷雼堧嫟.
Haemonetics (NYSE: HAE) a annonc茅 la disponibilit茅 de ses r茅sultats financiers du deuxi猫me trimestre de l'exercice 2025, clos le 28 septembre 2024, sur son site web de relations avec les investisseurs. L'entreprise animera une conf茅rence t茅l茅phonique et un webcast avec des investisseurs et des analystes le 7 novembre 2024, 脿 8h00 ET, pour discuter des r茅sultats. Il est recommand茅 aux participants de se connecter 10 minutes avant le d茅but de l'茅v茅nement. Un replay de la conf茅rence t茅l茅phonique et du webcast sera disponible pendant un an 脿 partir du 7 novembre 2024, 脿 11h00 ET.
Haemonetics (NYSE: HAE) hat die Verf眉gbarkeit seiner finanziellen Ergebnisse f眉r das zweite Quartal des Gesch盲ftsjahres 2025, das am 28. September 2024 endete, auf seiner Website f眉r Investor Relations bekannt gegeben. Das Unternehmen wird am 7. November 2024 um 8:00 Uhr ET eine Telefonkonferenz und einen Webcast mit Investoren und Analysten abhalten, um die Ergebnisse zu besprechen. Teilnehmer werden gebeten, 10 Minuten vor Beginn des Events beizutreten. Eine Wiederholung der Telefonkonferenz und des Webcasts wird ab dem 7. November 2024 um 11:00 Uhr ET f眉r ein Jahr verf眉gbar sein.
- None.
- None.
Insights
The announcement of an upcoming earnings release and conference call, without the actual financial figures, does not provide actionable information for investors. This is a routine administrative announcement that precedes the actual earnings release and discussion. Investors should wait for the actual earnings call and financial results to make informed decisions about HAE stock.
Financial release accessible online
The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on November 7, 2024. The conference call and webcast can be accessed with the following information:
- Teleconference link:听
- Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start.
- A live webcast of the call can be accessed on听Haemonetics' investor relations website or via the following link:
In addition, the Company has posted to its Investor Relations website the earnings release that will be referenced on its conference call and webcast, a link to which is available below.
Direct link to 2Q FY25 Earnings Release:
A replay of the conference call and webcast will be available for one year beginning on November 7, 2024, at 11:00 a.m. ET using the conference call webcast link provided in this press release.
ABOUT HAEMONETICS
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit .
Investor Contacts: | |
Olga Guyette, Vice President-Investor Relations & Treasury | David听Trenk, Manager-Investor Relations |
(781) 356-9763 | (203) 733-4987 |
听
Media Contact: | |
Josh Gitelson, Sr. Director-Global Communications | |
(781) 356-9776 | |
听
View original content to download multimedia:
SOURCE Haemonetics Corporation
FAQ
When will Haemonetics (HAE) release Q2 FY2025 earnings?
How can I access Haemonetics (HAE) Q2 FY2025 earnings call?
How long will Haemonetics (HAE) Q2 FY2025 earnings call replay be available?
